Delivery Order SPE2DB24D9144-SPE2DB24FCMEK
Award Date 5/24/24
Potential Completion Date 6/17/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $10,831.80, is a firm fixed-price delivery order for the supply of XOLAIR 150 MG/ML SYRINGE, a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,321.10, is for the delivery of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,160.55 firm fixed-price delivery order is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, a specialized pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGE medication. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,557.52 firm fixed-price delivery order covers the supply of XOLAIR 150 MG/ML SYRINGE to support the recurring medical supply needs of military health facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
- This federal contract award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,737.00 firm fixed-price delivery order is for the pharmaceutical product Xolair 150 mg/mL syringe. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,268.00 delivery order is for the supply of XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML, which is a specialized pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,547.40, is for the delivery of XOLAIR 150 MG/ML SYRINGE products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC allows the...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB24FCMEKDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,160.55 delivery order is for the pharmaceutical product XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML and has a firm fixed price. The award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This IDC, under the DLA's SPE2DB program, does not have a set-aside designation.
Generated 8/23/24, 4:34 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/24/24 |